# OnCo record shenzhen-targetrx (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/shenzhen-targetrx/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "shenzhen-targetrx" ;
  schema:name "Shenzhen TargetRx"@en ;
  schema:alternateName "Shenzhen TargetRx Co., Ltd."@en ;
  schema:description "Shenzhen TargetRx is a China-based biotechnology company running 4 late-stage cancer trials of TGRX-326, TGRX-814 and TGRX-678 in non-small-cell lung cancer, hodgkin lymphoma and acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/shenzhen-targetrx/>, <https://www.tjrbiosciences.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.tjrbiosciences.com>, <https://clinicaltrials.gov/search?lead=Shenzhen%20TargetRx%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/cml/> ;
  onco:drugs <https://onco.cc/drugs/tgrx-326/> ;
  onco:trials <https://onco.cc/trials/nct05955391/>, <https://onco.cc/trials/nct06453902/>, <https://onco.cc/trials/nct06206174/> .